$RIOT
Riot Platforms, Inc. Stock $riot

$riot Overview Financials Valuation SEC Filings Company Website

2012 Q3 Form 10-Q Financial Statement

#000107997312000601 Filed on August 07, 2012

Income Statement

Concept	2012 Q3	2012 Q2	2011 Q2
Revenue	$6.000K	$27.00K	$55.00K
YoY Change	-72.73%	-50.91%	-8.33%
Cost Of Revenue		$12.00	$2.749K
YoY Change		-99.56%	-90.84%
Gross Profit	$6.000K	$27.00K	$52.00K
YoY Change	-72.73%	-48.08%	73.33%
Gross Profit Margin	100.0%	100.0%	94.55%
Selling, General & Admin	$1.346M	$1.394M	$1.360M
YoY Change	-4.24%	2.46%	-35.84%
% of Gross Profit	22439.85%	5161.9%	2615.88%
Research & Development	$1.066M	$880.6K	$1.456M
YoY Change	-35.2%	-39.53%	11.17%
% of Gross Profit	17766.12%	3261.52%	2800.64%
Depreciation & Amortization	$91.00K	$93.00K	$102.7K
YoY Change	-7.14%	-9.44%	-14.42%
% of Gross Profit	1516.67%	344.44%	197.5%
Operating Expenses	$2.412M	$2.274M	$2.817M
YoY Change	-20.93%	-19.25%	-17.64%
Operating Profit	-$2.402M	-$2.247M	-$2.746M
YoY Change	-20.24%	-18.18%	-18.99%
Interest Expense			-$40.00K
YoY Change			0.0%
% of Operating Profit
Other Income/Expense, Net	-$58.46K	-$62.66K	-$41.04K
YoY Change	11.9%	52.69%
Pretax Income	-$2.460M	-$2.310M	-$2.790M
YoY Change	-19.61%	-17.2%	-18.42%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$2.460M	-$2.310M	-$2.787M
YoY Change	-19.71%	-17.12%	-18.51%
Net Earnings / Revenue	-41000.0%	-8555.56%	-5067.27%
Basic Earnings Per Share
Diluted Earnings Per Share	-$2.563M	-$9.625M	-$16.41M
COMMON SHARES
Basic Shares Outstanding	7.716M
Diluted Shares Outstanding

Balance Sheet

Concept	2012 Q3	2012 Q2	2011 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$10.20M	$11.20M	$7.100M
YoY Change	112.5%	57.75%	-56.71%
Cash & Equivalents	$9.837M	$10.95M	$6.108M
Short-Term Investments	$400.0K	$200.0K	$1.000M
Other Short-Term Assets	$500.0K	$100.0K	$200.0K
YoY Change	0.0%	-50.0%	0.0%
Inventory			$0.00
Prepaid Expenses
Receivables	$3.238K	$25.20K	$0.00
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$10.69M	$11.33M	$7.300M
YoY Change	101.78%	55.22%	-56.55%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.560M	$2.609M	$3.000M
YoY Change	-11.72%	-13.04%	-9.09%
Goodwill	$387.2K	$387.2K
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.569M	$1.582M	$0.00
YoY Change
Total Long-Term Assets	$4.129M	$4.191M	$4.700M
YoY Change	-12.14%	-10.84%	-7.84%
TOTAL ASSETS
Total Short-Term Assets	$10.69M	$11.33M	$7.300M
Total Long-Term Assets	$4.129M	$4.191M	$4.700M
Total Assets	$14.82M	$15.52M	$12.00M
YoY Change	48.24%	29.35%	-45.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$642.0K	$435.8K	$1.300M
YoY Change	-57.2%	-66.48%	62.5%
Accrued Expenses	$658.9K	$366.6K	$1.200M
YoY Change	-49.32%	-69.45%	71.43%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.600M	$900.0K	$100.0K
YoY Change	550.0%	800.0%	0.0%
Total Short-Term Liabilities	$4.298M	$1.978M	$2.600M
YoY Change	30.25%	-23.93%	8.33%
LONG-TERM LIABILITIES
Long-Term Debt	$800.0K	$2.400M	$2.500M
YoY Change	-68.0%	-4.0%	-3.85%
Other Long-Term Liabilities	$1.000M	$200.0K	$600.0K
YoY Change	66.67%	-66.67%	-14.29%
Total Long-Term Liabilities	$1.800M	$2.600M	$3.100M
YoY Change	-41.94%	-16.13%	-6.06%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.298M	$1.978M	$2.600M
Total Long-Term Liabilities	$1.800M	$2.600M	$3.100M
Total Liabilities	$6.061M	$4.554M	$5.700M
YoY Change	-5.29%	-20.1%	1.79%
SHAREHOLDERS EQUITY
Retained Earnings	-$71.73M	-$69.27M
YoY Change
Common Stock	$80.49M	$80.24M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$8.762M	$10.97M	$6.300M
YoY Change
Total Liabilities & Shareholders Equity	$14.82M	$15.52M	$12.00M
YoY Change	48.24%	29.35%	-45.21%

Cashflow Statement

Concept	2012 Q3	2012 Q2	2011 Q2
OPERATING ACTIVITIES
Net Income	-$2.460M	-$2.310M	-$2.787M
YoY Change	-19.71%	-17.12%	-18.51%
Depreciation, Depletion And Amortization	$91.00K	$93.00K	$102.7K
YoY Change	-7.14%	-9.44%	-14.42%
Cash From Operating Activities	-$540.0K	-$1.330M	-$2.200M
YoY Change	-73.79%	-39.55%	-33.53%
INVESTING ACTIVITIES
Capital Expenditures	-$50.00K	-$30.00K	-$60.00K
YoY Change	0.0%	-50.0%	-77.78%
Acquisitions
YoY Change
Other Investing Activities	-$180.0K	$350.0K	$290.0K
YoY Change	-87.5%	20.69%	-107.49%
Cash From Investing Activities	-$230.0K	$320.0K	$230.0K
YoY Change	-84.56%	39.13%	-105.56%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-350.0K	10.65M	-70.00K
YoY Change	133.33%	-15314.29%	-100.76%
NET CHANGE
Cash From Operating Activities	-540.0K	-1.330M	-2.200M
Cash From Investing Activities	-230.0K	320.0K	230.0K
Cash From Financing Activities	-350.0K	10.65M	-70.00K
Net Change In Cash	-1.120M	9.640M	-2.040M
YoY Change	-69.73%	-572.55%	-215.91%
FREE CASH FLOW
Cash From Operating Activities	-$540.0K	-$1.330M	-$2.200M
Capital Expenditures	-$50.00K	-$30.00K	-$60.00K
Free Cash Flow	-$490.0K	-$1.300M	-$2.140M
YoY Change	-75.62%	-39.25%	-29.61%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	204000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-675000	USD
CY2012Q2	appy	Additional Milestone Maximum Payments AdditionalMilestoneMaximumPayments	2000000	USD
CY2012Q2	appy	Basic And Diluted Weighted Average Number Of Shares Outstanding BasicAndDilutedWeightedAverageNumberOfSharesOutstanding	1948717
	appy	Basic And Diluted Weighted Average Number Of Shares Outstanding BasicAndDilutedWeightedAverageNumberOfSharesOutstanding	1778433
	appy	Basic And Diluted Weighted Average Number Of Shares Outstanding BasicAndDilutedWeightedAverageNumberOfSharesOutstanding	1340649
CY2011Q2	appy	Basic And Diluted Weighted Average Number Of Shares Outstanding BasicAndDilutedWeightedAverageNumberOfSharesOutstanding	1340649
	appy	Cumulative Realized Loss On Marketable Securities Maximum CumulativeRealizedLossOnMarketableSecuritiesMaximum	5000	USD
CY2012Q2	appy	License Agreement Maximum Milestone Payments LicenseAgreementMaximumMilestonePayments	2000000	USD
CY2012Q2	appy	License Fee Receivable LicenseFeeReceivable	1020000	USD
	appy	Marketable Securities Management Fees MarketableSecuritiesManagementFees	1071	USD
	appy	Marketable Securities Management Fees MarketableSecuritiesManagementFees	6343	USD
CY2012Q2	appy	Maximum Percentage Of Any Individual Short Term Marketable Securities In Investment Portfolio MaximumPercentageOfAnyIndividualShortTermMarketableSecuritiesInInvestmentPortfolio	0.18
CY2011Q4	appy	Other Other Long Term Assets OtherOtherLongTermAssets	9665	USD
CY2012Q2	appy	Other Other Long Term Assets OtherOtherLongTermAssets	6811	USD
CY2012Q2	appy	Percentage Of Investment Portfolio Cash And Cash Equivalent PercentageOfInvestmentPortfolioCashAndCashEquivalent	0.45
CY2011Q4	appy	Share Based Compensation Arrangement By Share Based Payment Award Other Options And Warrants Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherOptionsAndWarrantsOutstandingWeightedAverageExercisePrice	1.45
	appy	Stockholders Equity Note Reverse Stock Split Conversion Ratio StockholdersEquityNoteReverseStockSplitConversionRatio	6
	appy	Share Based Compensation Arrangement By Share Based Payment Award Other Options And Warrants Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherOptionsAndWarrantsForfeituresInPeriod	5449
CY2012Q2	appy	Share Based Compensation Arrangement By Share Based Payment Award Other Options And Warrants Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherOptionsAndWarrantsForfeituresInPeriodWeightedAverageExercisePrice	34.06
	appy	Weighted Average Number Of Shares Outstanding Basic And Diluted Extended WeightedAverageNumberOfSharesOutstandingBasicAndDilutedExtended	10700000
	appy	Weighted Average Number Of Shares Outstanding Basic And Diluted Extended WeightedAverageNumberOfSharesOutstandingBasicAndDilutedExtended	8027665
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2012
CY2012Q2	us-gaap	Common Stock Value CommonStockValue	80236505	USD
CY2011Q4	us-gaap	Assets Current AssetsCurrent	4321044	USD
CY2012Q2	us-gaap	Assets Current AssetsCurrent	11331170	USD
CY2011Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2725981	USD
CY2012Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2912180	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets		USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	-35531	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	840400
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	214500
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	44554	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	59503	USD
CY2011Q4	us-gaap	Assets Assets	8727845	USD
CY2012Q2	us-gaap	Assets Assets	15521909	USD
	dei	Document Period End Date DocumentPeriodEndDate	2012-06-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001167419
CY2012Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	7716480
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
	dei	Entity Registrant Name EntityRegistrantName	AspenBio Pharma, Inc.
CY2011Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	581713	USD
CY2012Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	435807	USD
CY2011Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	35016	USD
CY2012Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	25196	USD
CY2011Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	368406	USD
CY2012Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	366632	USD
CY2012Q2	us-gaap	Capital Capital	9353000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2968104	USD
CY2012Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10949955	USD
CY2010Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8908080	USD
CY2011Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6108117	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	7981851	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-2799963	USD
CY2011Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2011Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue
CY2012Q2	us-gaap	Common Stock No Par Value CommonStockNoParValue
CY2011Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000
CY2012Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000
CY2011Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1608146
CY2012Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7716480
CY2011Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1608146
CY2012Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7716480
CY2011Q4	us-gaap	Common Stock Value CommonStockValue	68846796	USD
	us-gaap	Comparability Of Prior Year Financial Data ComparabilityOfPriorYearFinancialData	<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> Reclassifications:</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> Certain prior period amounts in the accompanying financial statements have been reclassified to conform to the presentation used in 2012.</div> <!--EndFragment--></div> </div>
CY2012Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	12	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	196	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	15576	USD
CY2011Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	2749	USD
CY2011Q4	us-gaap	Deferred Revenue DeferredRevenue		USD
CY2012Q2	us-gaap	Deferred Revenue DeferredRevenue	204000	USD
CY2012Q2	us-gaap	Depreciation Depreciation	92600	USD
	us-gaap	Depreciation Depreciation	186200	USD
	us-gaap	Depreciation Depreciation	202400	USD
CY2011Q2	us-gaap	Depreciation Depreciation	102700	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	224452	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	252963	USD
CY2012Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.19
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.39
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-4.17
CY2011Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.08
CY2011Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	47622	USD
CY2012Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	275722	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-168753	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-198012	USD
	us-gaap	Interest Paid InterestPaid	125163	USD
CY2011Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	273550	USD
CY2012Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	308949	USD
CY2011Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1214748	USD
CY2012Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1187739	USD
	us-gaap	Future Amortization Expense Year Five FutureAmortizationExpenseYearFive	72000	USD
	us-gaap	Future Amortization Expense Year Four FutureAmortizationExpenseYearFour	72000	USD
	us-gaap	Future Amortization Expense Year One FutureAmortizationExpenseYearOne	72000	USD
	us-gaap	Future Amortization Expense Year Three FutureAmortizationExpenseYearThree	72000	USD
	us-gaap	Future Amortization Expense Year Two FutureAmortizationExpenseYearTwo	72000	USD
CY2011Q4	us-gaap	Goodwill Goodwill	387239	USD
CY2012Q2	us-gaap	Goodwill Goodwill	387239	USD
CY2012Q2	us-gaap	Gross Profit GrossProfit	27229	USD
	us-gaap	Gross Profit GrossProfit	34320	USD
	us-gaap	Gross Profit GrossProfit	137062	USD
CY2011Q2	us-gaap	Gross Profit GrossProfit	52573	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-145906	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	131155	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-9820	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-52696	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1774	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	792457	USD
	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	228100	USD
	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-205500	USD
	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	1072	USD
CY2011Q2	us-gaap	Licenses Revenue LicensesRevenue	17766	USD
CY2012Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	559000	USD
CY2012Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	442000	USD
CY2012Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	71000	USD
CY2012Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	68000	USD
CY2012Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	65000	USD
CY2012Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	2067000	USD
CY2011Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	2830041	USD
CY2012Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	2372537	USD
	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-82	USD
	us-gaap	Interest Paid InterestPaid	89314	USD
CY2012Q2	us-gaap	Investments And Cash InvestmentsAndCash	11160000	USD
CY2011Q4	us-gaap	Liabilities Liabilities	4901967	USD
CY2012Q2	us-gaap	Liabilities Liabilities	4554352	USD
CY2011Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8727845	USD
CY2012Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15521909	USD
CY2011Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2071926	USD
CY2012Q2	us-gaap	Liabilities Current LiabilitiesCurrent	1977815	USD
CY2012Q2	us-gaap	Licenses Revenue LicensesRevenue		USD
	us-gaap	Licenses Revenue LicensesRevenue		USD
	us-gaap	Licenses Revenue LicensesRevenue	35531	USD
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	1343	USD
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-2600	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	10306477	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-222709	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	740208	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1770112	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3064834	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4347366	USD
CY2012Q2	us-gaap	Net Income Loss NetIncomeLoss	-2309759	USD
	us-gaap	Net Income Loss NetIncomeLoss	-4248030	USD
	us-gaap	Net Income Loss NetIncomeLoss	-5593126	USD
CY2011Q2	us-gaap	Net Income Loss NetIncomeLoss	-2787292	USD
CY2012Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-62664	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-126733	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-73660	USD
CY2011Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-41040	USD
CY2011Q4	us-gaap	Notes Payable NotesPayable	3904226	USD
CY2012Q2	us-gaap	Notes Payable NotesPayable	3272191	USD
CY2011Q4	us-gaap	Notes Payable Current NotesPayableCurrent	1074185	USD
CY2012Q2	us-gaap	Notes Payable Current NotesPayableCurrent	899654	USD
CY2012Q2	us-gaap	Operating Expenses OperatingExpenses	2274324	USD
	us-gaap	Operating Expenses OperatingExpenses	4155617	USD
	us-gaap	Operating Expenses OperatingExpenses	5692059	USD
CY2011Q2	us-gaap	Operating Expenses OperatingExpenses	2816591	USD
CY2012Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2247095	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4121297	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-5519466	USD
CY2011Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2746252	USD
CY2011Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1611652	USD
CY2012Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1581789	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	52944	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	145273	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	65128	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	209714	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	312763	USD
CY2011Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	314800	USD
CY2012Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	146047	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	10938512	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		USD
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	1002866	USD
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	2293276	USD
CY2011Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5521130	USD
CY2012Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5521130	USD
CY2011Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2795149	USD
CY2012Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2608950	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	632035	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	222709	USD
CY2012Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	880610	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1557228	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2728330	USD
CY2011Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1456335	USD
CY2011Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-65020918	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	451197	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	675005	USD
CY2012Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-69268948	USD
CY2012Q2	us-gaap	Royalty Expense RoyaltyExpense	20000	USD
CY2012Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	27241	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	34516	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	152638	USD
CY2011Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	55322	USD
CY2012Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1393714	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2598389	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2963729	USD
CY2011Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1360256	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Term Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTermMaximum	5
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Term Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTermMinimum	3
CY2011Q4	us-gaap	Short Term Investments ShortTermInvestments	1003124	USD
CY2012Q2	us-gaap	Short Term Investments ShortTermInvestments	209972	USD
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	3825878	USD
CY2012Q2	us-gaap	Stockholders Equity StockholdersEquity	10967557	USD
	us-gaap	Stockholders Equity Note Changes In Capital Structure Subsequent Changes To Number Of Common Shares StockholdersEquityNoteChangesInCapitalStructureSubsequentChangesToNumberOfCommonShares	1800000
	us-gaap	Stockholders Equity Note Changes In Capital Structure Subsequent Changes To Number Of Common Shares StockholdersEquityNoteChangesInCapitalStructureSubsequentChangesToNumberOfCommonShares	1340649

Files In Submission

Name	View Source	Status
0001079973-12-000601-index-headers.html	Edgar Link	pending
0001079973-12-000601-index.html	Edgar Link	pending
0001079973-12-000601.txt	Edgar Link	pending
0001079973-12-000601-xbrl.zip	Edgar Link	pending
appy-20120630.xml	Edgar Link	completed
appy-20120630.xsd	Edgar Link	pending
appy-20120630_cal.xml	Edgar Link	unprocessable
appy-20120630_def.xml	Edgar Link	unprocessable
appy-20120630_lab.xml	Edgar Link	unprocessable
appy-20120630_pre.xml	Edgar Link	unprocessable
appy_10q-063012.htm	Edgar Link	pending
ex31x1.htm	Edgar Link	pending
ex31x2.htm	Edgar Link	pending
ex32.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RIOT
Riot Platforms, Inc. Stock $riot

2012 Q3 Form 10-Q Financial Statement

#000107997312000601 Filed on August 07, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RIOT Riot Platforms, Inc. Stock $riot

2012 Q3 Form 10-Q Financial Statement

#000107997312000601 Filed on August 07, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RIOT
Riot Platforms, Inc. Stock $riot